Sarepta Therapeutics,, Inc. Common Stock SRPT
$18.10
-1.74%
at last close
Financials (TTM)
- Revenue
- $1.97 billion
- Net Income
- $-136,725,000
- Net Margin
- -6.93%
- Return on Equity
- -8.95%
- Debt-to-Equity
- 0.55
- P/E Ratio
- —
- Price / Book
- 1.27
- Price / Sales
- 0.98
Over the trailing twelve months, Sarepta Therapeutics,, Inc. Common Stock generated revenue of $1.97 billion and net income of $-136,725,000, a net margin of -6.93%.
At the last closing price of $18.10, SRPT trades at 0.98 times sales, with a market capitalization of $1.94 billion.
Key Stats
- Last Close
- $18.10
- Market Cap
- $1.94 billion
- 52-Week Range
- $10.41 – $25.32
- Average Volume
- 3.07 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.